Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
Jonathan E. Rosenberg, Thomas B. Powles, Guru Sonpavde, Yohann Loriot, Ignacio Durán, J.-L. Lee and 8 more
- Rank
- 15 of 3,639
- Percentile
- top 0.5%
- Where
- Annals of Oncology, 2023
- Citations
- 171
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.